Skip to main content
Erschienen in: Journal of Genetic Counseling 4/2014

01.08.2014 | Next Generation Genetic Counseling

Factors Which Impact the Delivery of Genetic Risk Assessment Services Focused on Inherited Cancer Genomics: Expanding the Role and Reach of Certified Genetics Professionals

verfasst von: Cristi Radford, Anya Prince, Karen Lewis, Tuya Pal

Erschienen in: Journal of Genetic Counseling | Ausgabe 4/2014

Einloggen, um Zugang zu erhalten

Abstract

There is tremendous excitement about the promise of new genomic technologies to transform medical practice and improve patient care. Although the full power of genetic diagnosis has not yet been realized, paradigms of clinical decision-making are changing. In fact, recent policy level changes to promote genetic counseling by certified genetics professionals (GP) such as genetic counselors and clinical geneticists, are occurring at both the payer and state level. However, there remain opportunities to develop policies within the United States to: 1) enhance the access to the limited workforce of GPs; 2) revise reimbursement schemes such that costs to deliver these services may be recouped by institutions with GPs; and 3) protect against the potential for discrimination based on genetic information. Although many of these issues predate advances in genomic technologies, they are exacerbated by them, with increasing access and awareness as costs of testing decrease. Consequently, evolving shifts in national policies poise GPs to serve as a hub of information and may be instrumental in facilitating new models to deliver genetics-based care through promoting academic-community partnerships and interfacing with non-GPs. As we acknowledge the potential for genomics to revolutionize medical practice, the expertise of GPs may be leveraged to facilitate incorporation of this information into mainstream medicine.
Literatur
Zurück zum Zitat American College of Obstetricians and Gynecologists; ACOG Committee on Practice Bulletins--Gynecology; ACOG Committee on Genetics; Society of Gynecologic Oncologists (2009). ACOG Practice Bulletin No. 103: hereditary breast and ovarian cancer syndrome. Obstetrics and Gynecology, 113(4), 957–966. American College of Obstetricians and Gynecologists; ACOG Committee on Practice Bulletins--Gynecology; ACOG Committee on Genetics; Society of Gynecologic Oncologists (2009). ACOG Practice Bulletin No. 103: hereditary breast and ovarian cancer syndrome. Obstetrics and Gynecology, 113(4), 957–966.
Zurück zum Zitat Acheson, L. S., Stange, K. C., & Zyzanski, S. (2005). Clinical genetics issues encountered by family physicians. Genetics in Medicine, 7(7), 501–508.PubMedCrossRef Acheson, L. S., Stange, K. C., & Zyzanski, S. (2005). Clinical genetics issues encountered by family physicians. Genetics in Medicine, 7(7), 501–508.PubMedCrossRef
Zurück zum Zitat Baars, M. J., Henneman, L., & Ten Kate, L. P. (2005). Deficiency of knowledge of genetics and genetic tests among general practitioners, gynecologists, and pediatricians: a global problem. Genetics in Medicine, 7(9), 605–610.PubMedCrossRef Baars, M. J., Henneman, L., & Ten Kate, L. P. (2005). Deficiency of knowledge of genetics and genetic tests among general practitioners, gynecologists, and pediatricians: a global problem. Genetics in Medicine, 7(9), 605–610.PubMedCrossRef
Zurück zum Zitat Baruch, S., & Hudson, K. (2008). Civilian and military genetics: nondiscrimination policy in a post-GINA world. American Journal of Human Genetics, 83(4), 435–444.PubMedPubMedCentralCrossRef Baruch, S., & Hudson, K. (2008). Civilian and military genetics: nondiscrimination policy in a post-GINA world. American Journal of Human Genetics, 83(4), 435–444.PubMedPubMedCentralCrossRef
Zurück zum Zitat Cohen, S. A., & McIlvried, D. E. (2013). Improving access with a collaborative approach to cancer genetic counseling services: a pilot study. Community Oncology, 10(8), 227–234.CrossRef Cohen, S. A., & McIlvried, D. E. (2013). Improving access with a collaborative approach to cancer genetic counseling services: a pilot study. Community Oncology, 10(8), 227–234.CrossRef
Zurück zum Zitat Cohen, S. A., McIlvried, D., & Schnieders, J. (2009). A collaborative approach to genetic testing: a community hospital’s experience. Journal of Genetic Counseling, 18(6), 530–533.PubMedCrossRef Cohen, S. A., McIlvried, D., & Schnieders, J. (2009). A collaborative approach to genetic testing: a community hospital’s experience. Journal of Genetic Counseling, 18(6), 530–533.PubMedCrossRef
Zurück zum Zitat Dancey, J. E., Bedard, P. L., Onetto, N., & Hudson, T. J. (2012). The genetic basis for cancer treatment decisions. Cell, 148(3), 409–420.PubMedCrossRef Dancey, J. E., Bedard, P. L., Onetto, N., & Hudson, T. J. (2012). The genetic basis for cancer treatment decisions. Cell, 148(3), 409–420.PubMedCrossRef
Zurück zum Zitat Giardiello, F. M., Brensinger, J. D., Petersen, G. M., Luce, M. C., Hylind, L. M., Bacon, J. A., et al. (1997). The use and interpretation of commercial APC gene testing for familial adenomatous polyposis. New England Journal of Medicine, 336(12), 823–827.PubMedCrossRef Giardiello, F. M., Brensinger, J. D., Petersen, G. M., Luce, M. C., Hylind, L. M., Bacon, J. A., et al. (1997). The use and interpretation of commercial APC gene testing for familial adenomatous polyposis. New England Journal of Medicine, 336(12), 823–827.PubMedCrossRef
Zurück zum Zitat Green, R. C., Berg, J. S., Grody, W. W., Kalia, S. S., Korf, B. R., Martin, C. L., et al. (2013). ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genetics in Medicine, 15(7):565–574.PubMedPubMedCentralCrossRef Green, R. C., Berg, J. S., Grody, W. W., Kalia, S. S., Korf, B. R., Martin, C. L., et al. (2013). ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genetics in Medicine, 15(7):565–574.PubMedPubMedCentralCrossRef
Zurück zum Zitat Grosse, S. D., & Khoury, M. J. (2006). What is the clinical utility of genetic testing? Genetics in Medicine, 8(7), 448–450.PubMedCrossRef Grosse, S. D., & Khoury, M. J. (2006). What is the clinical utility of genetic testing? Genetics in Medicine, 8(7), 448–450.PubMedCrossRef
Zurück zum Zitat Institute of Medicine. (2009). Innovations in service delivery in the age of genomics: Workshop summary. Washing, D.C.: The National Academies Press. Institute of Medicine. (2009). Innovations in service delivery in the age of genomics: Workshop summary. Washing, D.C.: The National Academies Press.
Zurück zum Zitat Leib, J. R., Hoodfar, E., Haidle, J. L., & Nagy, R. (2008). The new genetic privacy law. Community Oncology, 5(6), 124–127.CrossRef Leib, J. R., Hoodfar, E., Haidle, J. L., & Nagy, R. (2008). The new genetic privacy law. Community Oncology, 5(6), 124–127.CrossRef
Zurück zum Zitat MacDonald, D. J., Blazer, K. R., & Weitzel, J. N. (2010). Extending comprehensive cancer center expertise in clinical cancer genetics and genomics to diverse communities: the power of partnership. Journal of the National Comprehensive Cancer Network, 8(5), 615–624.PubMedPubMedCentralCrossRef MacDonald, D. J., Blazer, K. R., & Weitzel, J. N. (2010). Extending comprehensive cancer center expertise in clinical cancer genetics and genomics to diverse communities: the power of partnership. Journal of the National Comprehensive Cancer Network, 8(5), 615–624.PubMedPubMedCentralCrossRef
Zurück zum Zitat McPherson, E., Zaleski, C., Benishek, K., McCarty, C. A., Giampietro, P. F., Reynolds, K., et al. (2008). Clinical genetics provider real-time workflow study. Genetics in Medicine, 10(9), 699–706.PubMedCrossRef McPherson, E., Zaleski, C., Benishek, K., McCarty, C. A., Giampietro, P. F., Reynolds, K., et al. (2008). Clinical genetics provider real-time workflow study. Genetics in Medicine, 10(9), 699–706.PubMedCrossRef
Zurück zum Zitat National Accreditation Program for Breast Centers. (2013). Genetic evaluation and management (page 48). Retrieved June 15, 2013. National Accreditation Program for Breast Centers. (2013). Genetic evaluation and management (page 48). Retrieved June 15, 2013.
Zurück zum Zitat Riley, B. D., Culver, J. O., Skrzynia, C., Senter, L. A., Peters, J. A., Costalas, J. W., et al. (2012). Essential elements of genetic cancer risk assessment, counseling, and testing: updated recommendations of the National Society of Genetic Counselors. Journal of Genetic Counseling, 21(2), 151–161. doi:https://doi.org/10.1007/s10897-011-9462-x.PubMedCrossRef Riley, B. D., Culver, J. O., Skrzynia, C., Senter, L. A., Peters, J. A., Costalas, J. W., et al. (2012). Essential elements of genetic cancer risk assessment, counseling, and testing: updated recommendations of the National Society of Genetic Counselors. Journal of Genetic Counseling, 21(2), 151–161. doi:https://​doi.​org/​10.​1007/​s10897-011-9462-x.PubMedCrossRef
Zurück zum Zitat Trepanier, A., Ahrens, M., McKinnon, W., Peters, J., Stopfer, J., Grumet, S. C., et al. (2004). Genetic cancer risk assessment and counseling: recommendations of the national society of genetic counselors. Journal of Genetic Counseling, 13(2), 83–114.CrossRef Trepanier, A., Ahrens, M., McKinnon, W., Peters, J., Stopfer, J., Grumet, S. C., et al. (2004). Genetic cancer risk assessment and counseling: recommendations of the national society of genetic counselors. Journal of Genetic Counseling, 13(2), 83–114.CrossRef
Zurück zum Zitat Vig, H. S., Armstrong, J., Egleston, B. L., Mazar, C., Toscano, M., Bradbury, A. R., et al. (2009). Cancer genetic risk assessment and referral patterns in primary care. Genetic Testing and Molecular Biomarkers, 13(6), 735–741.PubMedPubMedCentralCrossRef Vig, H. S., Armstrong, J., Egleston, B. L., Mazar, C., Toscano, M., Bradbury, A. R., et al. (2009). Cancer genetic risk assessment and referral patterns in primary care. Genetic Testing and Molecular Biomarkers, 13(6), 735–741.PubMedPubMedCentralCrossRef
Zurück zum Zitat Wideroff, L., Vadaparampil, S. T., Greene, M. H., Taplin, S., Olson, L., & Freedman, A. N. (2005). Hereditary breast/ovarian and colorectal cancer genetics knowledge in a national sample of US physicians. Journal of Medical Genetics, 42(10), 749–755.PubMedPubMedCentralCrossRef Wideroff, L., Vadaparampil, S. T., Greene, M. H., Taplin, S., Olson, L., & Freedman, A. N. (2005). Hereditary breast/ovarian and colorectal cancer genetics knowledge in a national sample of US physicians. Journal of Medical Genetics, 42(10), 749–755.PubMedPubMedCentralCrossRef
Zurück zum Zitat Wilkins-Haug, L., Erickson, K., Hill, L., Power, M., Holzman, G. B., & Schulkin, J. (2000). Obstetrician-gynecologists’ opinions and attitudes on the role of genetics in women’s health. Journal of Women’s Health & Gender-Based Medicine, 9(8), 873–879.CrossRef Wilkins-Haug, L., Erickson, K., Hill, L., Power, M., Holzman, G. B., & Schulkin, J. (2000). Obstetrician-gynecologists’ opinions and attitudes on the role of genetics in women’s health. Journal of Women’s Health & Gender-Based Medicine, 9(8), 873–879.CrossRef
Metadaten
Titel
Factors Which Impact the Delivery of Genetic Risk Assessment Services Focused on Inherited Cancer Genomics: Expanding the Role and Reach of Certified Genetics Professionals
verfasst von
Cristi Radford
Anya Prince
Karen Lewis
Tuya Pal
Publikationsdatum
01.08.2014
Verlag
Springer US
Erschienen in
Journal of Genetic Counseling / Ausgabe 4/2014
Print ISSN: 1059-7700
Elektronische ISSN: 1573-3599
DOI
https://doi.org/10.1007/s10897-013-9668-1

Weitere Artikel der Ausgabe 4/2014

Journal of Genetic Counseling 4/2014 Zur Ausgabe

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

Blutdrucksenkung könnte Uterusmyome verhindern

Frauen mit unbehandelter oder neu auftretender Hypertonie haben ein deutlich erhöhtes Risiko für Uterusmyome. Eine Therapie mit Antihypertensiva geht hingegen mit einer verringerten Inzidenz der gutartigen Tumoren einher.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.